Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Sarasota Growth Ventures (SGV) is a venture capital firm established to merge venture capital with specialized knowledge in product development and manufacturing, particularly within the MedTech sector. Founded in Sarasota, Florida, SGV focuses on early-stage investments, providing essential guidance to entrepreneurs in areas such as concept validation, business model refinement, and regulatory insights. The firm operates with a target fund size of $25-30 million and aims to manage a portfolio of 10-20 companies.
SGV has carved a niche in the venture capital landscape by emphasizing capital-efficient growth strategies. The firm prioritizes investments in physical product ventures, particularly those that demonstrate validated demand and possess clear pathways to strategic exits. Notably, SGV maintains a low focus on IPO aspirations, instead favoring partnerships with strategic acquirers.
Sarasota Growth Ventures concentrates its investment strategy on physical product ventures, with a strong emphasis on the MedTech sector. The firm primarily invests at the pre-seed, seed, and seed-plus stages, targeting companies that have developed working prototypes and possess defendable intellectual property. SGV's investment strategy is designed to promote capital-efficient growth, focusing on manufacturing optimization and the potential for strategic exits.
SGV seeks to partner with entrepreneurs who demonstrate a clear understanding of their market and have validated demand for their products. The firm’s approach includes providing early-stage guidance on regulatory challenges and market entry strategies, ensuring that portfolio companies are well-prepared for the complexities of the MedTech industry.
Michael Dillhyon - General Partner. Michael has extensive experience in venture capital and product development, focusing on the MedTech sector.
Phoebe Bishop - Managing Partner. Phoebe brings a wealth of knowledge in early-stage investments and has a strong background in guiding startups through regulatory challenges.
Rob Brady - Venture Partner. Rob has a proven track record in the MedTech industry, specializing in strategic exits and operational support for portfolio companies.
Brandon Woodward - Investment Analyst Intern. Brandon supports the investment team with market research and analysis, contributing to the firm’s investment strategy.
Startups interested in pitching to Sarasota Growth Ventures should submit their proposals through the firm’s website at srq.ventures. It is recommended to include a comprehensive business plan, details about the product's market potential, and information on the team’s expertise. Response times may vary, so founders should be prepared for potential follow-up discussions.
What are the investment criteria for Sarasota Growth Ventures?
SGV targets early-stage investments in physical product ventures, particularly in the MedTech sector. They look for companies with validated demand, working prototypes, and defendable intellectual property.
How can startups apply or pitch to SGV?
Startups can pitch to Sarasota Growth Ventures through their website at srq.ventures. It is advisable to include a detailed business plan and information about the product's market potential.
What makes Sarasota Growth Ventures different from other VC firms?
SGV integrates venture capital with expertise in product development and manufacturing, particularly in the MedTech sector. This unique combination allows them to provide valuable early-stage guidance to entrepreneurs.
What is the geographic scope of SGV's investments?
Sarasota Growth Ventures primarily focuses on investments within the United States, specifically targeting early-stage MedTech companies.
What is the typical check size for investments?
While specific check sizes are not disclosed, SGV's target fund size is between $25-30 million, indicating a focus on capital-efficient investments in their portfolio companies.
What kind of post-investment involvement does SGV have?
SGV provides ongoing support to portfolio companies, particularly in areas such as regulatory insights and business model refinement, ensuring that startups are well-equipped to navigate the challenges of the MedTech industry.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.